## **Trustees' Annual Report for the period** 

Period start date Period end date **T** Day Month Year Day Month Year **From** 01 Nov 2022 **o** 31 Oct 2023 

## Section A                        Reference and administration details 

**Charity name** 

Allez Charity Events 

**Other names charity is known by** 

Fireflies Europe 

**Registered charity number (if any)** 1164828 

## **Charity's principal address** Mount Pleasant Studios 

51-53 Mount Pleasant 

London 

**Postcode WC1X 0AE** 

## **Names of the charity trustees who manage the charity** 

**Trustee name Office (if any)** 

**Dates acted if not for whole year** 

**Name of person (or body) entitled to appoint trustee (if any)** 

- 1 Paul Adler 

- 2[Richard ] Lewisohn 

- 3 Chris Page 

- 4 John Mawhood 

- 5[Timothy McCoy-] Page 

- 6 John Taylor 

- 7 

- 8 

- 9 

10 

11 

- 12 

- 13 

14 

March **2012** 

**TAR** 

1 



15 16 17 18 19 20 **Names of the trustees for the charity, if any, (for example, any custodian trustees)** 

**Name Dates acted if not for whole year** 

## **Names and addresses of advisers (Optional information)** 

|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|
|---|---|---|---|
|**Type of adviser**<br>**Name**<br>**Address**||||
|||||
|||||
|||||
|||||
|**Name of chief executive or names of senior staff members (Optional information)**||||
|||||



## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

Type of governing document (eg. trust deed, constitution) Constitution dated 23 October 2015 How the charity is constituted (eg. trust, association, company) Charitable Incorporated Organisation Trustee selection methods (eg. appointed by, elected by) Appointed by agreement of the existing trustees, for a term of between two and four years. 

## **Additional governance issues (Optional information)** 

March **2012** 

**TAR** 

2 



You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

In selecting individuals for appointment as charity trustees, the existing charity trustees have regard to the skills, knowledge and experience needed for the effective administration of the CIO and will enhance this through induction and training where appropriate. 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

**Summary of the objects of the charity set out in its governing document** 

The object of the CIO is to advance such charitable purposes (according to the law of England and Wales) as the trustees see fit from time to time in particular but not limited to the advancement of research into potential cures and treatments of blood cancers, for the public benefit of those persons currently suffering from these diseases, and those who may in the future be diagnosed with these diseases.  The CIO will in particular but not exclusively organise fundraising events, and make donations or grants in furtherance of its object. 

March **2012** 

**TAR** 

3 



The trustees have had regard to the guidance issued by the Charity Commission on public benefit.  The CIO makes one or more donations to carefully selected organisations, consistent with its object. 

**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

Research into potential cures and treatments for blood cancer provides a clear public benefit in reducing the risk of contracting diseases such as Leukaemia and Lymphoma, and increasing the possibility for patients to make a successful recovery. There are several renowned organisations operating in the UK, which have demonstrated through their research and clinical practice, substantially positive outcomes for patients and have communicated their know-how more widely, through peer-reviewed publications and conferences. They participate in important initiatives, which promote pan-European and other international collaboration in research and clinical excellence in treating blood cancers. 

The section of the UK public who will benefit most from the work of our CIO is those persons who are currently suffering from a blood cancer, and those who may in the future be diagnosed with a blood-cancer related disease. 

## **Additional details of objectives and activities (Optional information)** 

The trustees follow a thorough process to identify suitable recipient(s) of the funds that we raise: typically either another charity, which closely aligns with our object (ie. focused on cancer research) or for example a renowned research team associated with a hospital cancer treatment ward. 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

We go through both a vetting process, including visit(s) to potential recipient(s) where appropriate, and a verification process (postdonation) to receive feedback on how our donated funds have been used. 

There is an annual review of the effectiveness of these processes and corrective steps are taken where necessary to ensure that the funds we have raised are used according to our declared object.  We continue to communicate with Professor Jane Apperley, the principal of Imperial Health Charity (Blood Fund) and through the discussions have been able to review and verify the satisfactory use of the grant made during 2023, and look ahead to plans for 2024. 

The CIO is entirely organised and staffed by volunteers, to whom we are very grateful.  The trustees and others donate the use of premises and facilities required for our fundraising operations. 

March **2012** 

**TAR** 

4 



Section D                      Achievements and performance 

**Summary of the main achievements of the charity during the year** 

In the CIO’s eighth year of operation, donations totalling £300 were made to Imperial Health Charity (further designated for the Blood Fund); having been agreed by the trustees to be consistent with our object. This was facilitated in part by the generosity of Paul Adler, one of our trustees, who re-designated his original £200 loan to our charity as a donation. A formal grant-making policy is yet to be developed, but would be based on the principles explained in the preceding paragraphs. The trustees remain at the heart of the decision-making process and other beneficiaries may be considered for future years. Fundraising events have not yet been restarted, though we did continue to sell branded clothing. Insurance cover primarily relates to the cycling training (see below), which according to our assessment is the main risk. The trustees act as the main officers of the Fireflies Cycling Club. 

The CIO was able to attract over 20 members to join the “Fireflies Cycling Club” which organises training for novice and improver cyclists enabling them to participate successfully and safely in endurance cycling events. Meetings of the trustees were held virtually, including with sister groups around the world, which have similar objectives. 

March **2012** 

**TAR** 

5 



## **Section E** 

**Section E Financial review Brief statement of the charity’s** The CIO aims to maintain around 12-18 months’ worth of expenditure in **policy on reserves** the current account, in order to facilitate investment in future fundraising activities without assuming undue risk. **Details of any funds materially in deficit Further financial review details (Optional information)** 

You **may choose** to include Two of the trustees have agreed for the time being, to maintain their additional information, where interest-free loans to the CIO of £200 each. relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- • how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 

## **Section F** 

## **Other optional information** 

## **Section G Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s)**|||||
|---|---|---|---|---|
||||||
||||||
|**Full name(s)**||chris page|Tim McCoy-Page||
||||||



March **2012** 

**TAR** 

6 



**Position (eg Secretary, Chair, etc)** 

Trustee 

Trustee 

**Date** 21/11/23 

March **2012** 

**TAR** 

7 



||**Allez Charity Events**|**Allez Charity Events**|**Allez Charity Events**|**Allez Charity Events**|**Allez Charity Events**|**1164828**|**1164828**||**CC16a**||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||
||**Receipts andpayments accounts**||||||||||
||**For the period**<br>**from**||01/11/2022||**To**||31/10/2023||||
||||||||||||
||||||||||||
|**Section A Receipts and payments**|||||||||||
||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||**Total funds**||**Last year**||
||**to the nearest      £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||||
|Charitable Donations|||**-**||**-**||**-**||**-**||
|Membership Subscriptions|**330**||**-**||**-**||**330**||**375**||
|Sales of Clothing (for Fundraising)|**20**||**-**||**-**||**20**||**1,476**||
|Incidental Sales at Fundraising Events|||**-**||**-**||**-**||**-**||
|Trustee Loans (Repayable)|||**-**||**-**||**-**||||
|HMRC Gift Aid Refund|||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR) _|<br>**350**||**-**||**-**||**350**||**1,851**||
||||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||||||
||||||||**-**||||
||||||||**-**||||
|**_Sub total_**|||||||**-**||||
||||||||||||
|**_Total receipts_ **|<br>**350**||||||**350**||**1,851**||
||||||||||||
|**A3 Payments**|||||||||||
|Accounting & Website Software|**152**||**-**||**-**||**152**||**249**||
|Bank Fees|**10**||**-**||**-**||**10**||**45**||
|Charitable Donations - Imperial Healthcare/<br>Blood Fund|**300**||**-**||**-**||**300**||**500**||
|Payments to Clothing Suppliers|||**-**||**-**||**-**||**1,220**||
|Insurance|**74**||**-**||**-**||**74**||||
|Incidental Costs of Fundraising Events|||**-**||**-**||**-**||**-**||
|Sundry Postage, Courier, Stationery|||**-**||**-**||**-**||||
||||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||
|**_Sub total_ **|<br>**536**||**-**||**-**||**536**||**2,014**||
||||||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||||||
||||||||**-**||||
||||||||**-**||||
|**_Sub total_**|||||||**-**||||
||||||||||||
|**_Total payments_ **|<br>**536**||||||**536**||**2,014**||
||||||||||||
|**_Net of receipts/(payments)_ **|**-**<br>**186**||**-**||**-**||**-**<br>**186**||**-**<br>**163**||
|**A5 Transfers between funds**|||**-**||**-**||**-**||**-**||
|**A6 Cash funds lastyear end**|**2,584**||**-**||**-**||**2,584**||**2,747**||
|**_Cash funds thisyear end_ **|<br>**2,398**||**-**||**-**||**2,398**||**2,584**||
||||||||||||
||||||||||||
|**Section B Statement of assets and liabilities at the end of the period**|||||||||||
|**Categories**|**Details**||||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||
||||||**to nearest £**||**to nearest £**||**to nearest £**||
|**B1 Cash funds**|Balance at Barclays Bank||||**2,398**||**-**||**-**||
||||||**-**||**-**||**-**||
||||||**-**||**-**||**-**||
||**_Total cash funds_**||||**2,398**||**-**||**-**||
||(agree balances with receipts and payments<br>account(s))||||OK||||OK||
||||||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||
||**Details**||||**to nearest £**||**to nearest £**||**to nearest £**||



||**Allez Charity Events**|**Allez Charity Events**|**Allez Charity Events**|**Allez Charity Events**|**Allez Charity Events**|**1164828**|**1164828**||**CC16a**||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||
||**Receipts andpayments accounts**||||||||||
||**For the period**<br>**from**||01/11/2022||**To**||31/10/2023||||
||||||||||||
||||||||||||
|**Section A Receipts and payments**|||||||||||
||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||**Total funds**||**Last year**||
||**to the nearest      £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||||
|Charitable Donations|||**-**||**-**||**-**||**-**||
|Membership Subscriptions|**330**||**-**||**-**||**330**||**375**||
|Sales of Clothing (for Fundraising)|**20**||**-**||**-**||**20**||**1,476**||
|Incidental Sales at Fundraising Events|||**-**||**-**||**-**||**-**||
|Trustee Loans (Repayable)|||**-**||**-**||**-**||||
|HMRC Gift Aid Refund|||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR) _|<br>**350**||**-**||**-**||**350**||**1,851**||
||||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||||||
||||||||**-**||||
||||||||**-**||||
|**_Sub total_**|||||||**-**||||
||||||||||||
|**_Total receipts_ **|<br>**350**||||||**350**||**1,851**||
||||||||||||
|**A3 Payments**|||||||||||
|Accounting & Website Software|**152**||**-**||**-**||**152**||**249**||
|Bank Fees|**10**||**-**||**-**||**10**||**45**||
|Charitable Donations - Imperial Healthcare/<br>Blood Fund|**300**||**-**||**-**||**300**||**500**||
|Payments to Clothing Suppliers|||**-**||**-**||**-**||**1,220**||
|Insurance|**74**||**-**||**-**||**74**||||
|Incidental Costs of Fundraising Events|||**-**||**-**||**-**||**-**||
|Sundry Postage, Courier, Stationery|||**-**||**-**||**-**||||
||||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||
|**_Sub total_ **|<br>**536**||**-**||**-**||**536**||**2,014**||
||||||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||||||
||||||||**-**||||
||||||||**-**||||
|**_Sub total_**|||||||**-**||||
||||||||||||
|**_Total payments_ **|<br>**536**||||||**536**||**2,014**||
||||||||||||
|**_Net of receipts/(payments)_ **|**-**<br>**186**||**-**||**-**||**-**<br>**186**||**-**<br>**163**||
|**A5 Transfers between funds**|||**-**||**-**||**-**||**-**||
|**A6 Cash funds lastyear end**|**2,584**||**-**||**-**||**2,584**||**2,747**||
|**_Cash funds thisyear end_ **|<br>**2,398**||**-**||**-**||**2,398**||**2,584**||
||||||||||||
||||||||||||
|**Section B Statement of assets and liabilities at the end of the period**|||||||||||
|**Categories**|**Details**||||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||
||||||**to nearest £**||**to nearest £**||**to nearest £**||
|**B1 Cash funds**|Balance at Barclays Bank||||**2,398**||**-**||**-**||
||||||**-**||**-**||**-**||
||||||**-**||**-**||**-**||
||**_Total cash funds_**||||**2,398**||**-**||**-**||
||(agree balances with receipts and payments<br>account(s))||||OK||||OK||
||||||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||
||**Details**||||**to nearest £**||**to nearest £**||**to nearest £**||



CCXX R1 accounts (SS) 

19/11/2023 

1 



|**B2 Other monetary assets**|||||**-**||**-**||**-**||
|---|---|---|---|---|---|---|---|---|---|---|
||||||**-**||**-**||**-**||
||||||**-**||**-**||**-**||
||||||**-**||**-**||**-**||
||||||**-**||**-**||**-**||
||||||**-**||**-**||**-**||
||||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||**Current value**<br>**(optional)**||
|**B3 Investment assets**|||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||||||
||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||**Current value**<br>**(optional)**||
|**B4 Assets retained for the**<br>**charity’s own use**|Stock of merchandise retained for future<br>fundraising sales||||unrestricted||**150**||**100**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||**-**||**-**||
||||||||||||
||**Details**||||**Fund to which**<br>**liability relates**||**Amount due**<br>**(optional)**||**When due**<br>**(optional)**||
|**B5 Liabilities**|Balances due for Clothing Purchases||||||**-**||||
||Repayment of Trustee Loans||||||**400**||**by agreement**||
||||||||**-**||||
||||||||**-**||||
||||||||**-**||||
||||||||||||
|Signed by one or two trustees on behalf<br>of all the trustees|Signature||||Print Name||||Date of approval||
||||||||||||
||||||||||||
||||||||||||
||||||||||||




Tim McCoy-Page 21/11/23 

CCXX R2 accounts (SS) 

19/11/2023 

2 

